The most popular stories and special reports in FierceBiotech Research, FiercePharmaManufacturing, and the rest of our Life Sciences publications

We hope you've found this year's roundup of the most popular content on the web interesting. Below, you'll find the top-visited stories and special reports from each of our weekly and semi-weekly publications this year. The content is listed by popularity in descending order.

We'll be back on Monday with our regular coverage. Enjoy the leftovers.

Suggested Articles

The data, from two patients with severe blood disorders, are "promising” for what could be a one-and-done treatment, Cantor Fitzgerald analysts wrote.

The fund will back pharma companies as well as developers of medtech products and providers of outsourced services.

The money will fund work to develop polymers in multiple indications and an associated U.S. expansion.